Through experimental verification, Zhao et al. [73] found that clinical studies on liver cancer showed that ESR1 and EGFR mRNA expressions increased, while in vitro experiment data showed that the intracellular contents of ESR1 and EGFR mRNA decreased in liver cancer cells treated with oxyresveratrol. The gene discussed is EGFR; the disease is liver cancer.